BIO 2025 this year came at a uniquely fraught moment for vaccination in the United States just days after HHS Secretary ...

Originally employed in atomic physics, mass spectrometry is now an indispensable tool in modern science, and importantly ...

Just a year ago, the GenAI buzz in pharma felt like the start of a gold rush. Leaders greenlit pilots. Teams spun up proof-of ...

However, in both cases, NICE immediately published draft guidance that concluded the anti-amyloid drugs were too expensive to ...

From the practical wisdom of emphasising exercise to improve survival in colon cancer to the association of glucagon-like ...

Gilead is now waiting for regulatory decisions on the twice-yearly PrEP in Europe and other markets, including South Africa ...

Skyclarys is an important growth product for Biogen, which has been hit in the last few years by a series of pipeline ...

US Senators Bernie Sanders and Angus King have introduced a bill that seeks to ban direct-to-consumer (DTC) advertising by ...

EY's latest Biotech Beyond Borders report acknowledges the seismic changes in the US in the last few months, including cuts ...

Published in the Journal of the American Medical Association (JAMA), the letter says that the dismissal of the advisors and ...

Small transactions may not always make the headlines, but they’re the lifeblood of pharma innovation. So says Juergen ...

The announcement builds on AZ's announcement earlier this year that it will invest $2.5 billion in an R&D facility in China, ...